ACCP JOURNALS
Ein Podcast von ACCP JOURNALS
162 Folgen
-
Role of ID Pharmacists in OPAT & COpAT - Episode 62
Vom: 5.9.2021 -
A Focus on Mitigation Strategies - Episode 61
Vom: 20.8.2021 -
Consistent & Efficient Comprehensive Medication Management through Telemedicine - Episode 60
Vom: 2.8.2021 -
Virtual OSCEs for Pharmacy Students - Episode 59
Vom: 19.7.2021 -
Smartphone ECG monitoring for QT prolongation - Episode 58
Vom: 22.6.2021 -
Health System Cyberattack - Episode 57
Vom: 11.6.2021 -
Enoxaparin vs. UFH for VTE Prophylaxis in Renally Impaired - Ep 56
Vom: 17.5.2021 -
Forces driving change in pharmacy education - Episode 55
Vom: 11.5.2021 -
Drive-up INR testing in a rural anticoagulation clinic - Episode 54
Vom: 19.4.2021 -
Psychiatric Medication Use by College Students - Episode 53
Vom: 13.4.2021 -
Optimizing secondary stroke/TIA prophylaxis therapy - Episode 52
Vom: 19.3.2021 -
Digoxin & Mortality - Episode 51
Vom: 18.3.2021 -
Therapeutic Drug Monitoring of Beta-Lactam Antibiotics - Episode 50
Vom: 4.3.2021 -
Clinical Pharmacy Education & Training - Episode 49
Vom: 16.2.2021 -
Competency-based clinical pharmacogenomic activities during an APPE - Episode 48
Vom: 5.2.2021 -
Pharmacotherapy Issues in Solid Organ Transplantation
Vom: 6.1.2021 -
Drug-induced Ototoxicity – Episode 46
Vom: 18.12.2020 -
History of Pharmacy Specialization in the US - Episode 45
Vom: 16.12.2020 -
Prescribing Errors in Patients Discharged from the Emergency Department - Episode 44
Vom: 16.11.2020 -
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19 - Part II, episode 43
Vom: 13.11.2020
This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.